Analysis and compensation of RF impairments for next generation multimode GNSS receivers

Global navigation satellite system (GNSS) receivers require solutions that are compact, cheap and low-power, in order to enable their widespread proliferation into consumer products. Furthermore, interoperability of GNSS with non-navigation systems, especially communication systems will gain importance in providing the value added services in a variety of sectors, providing seamless quality of service for users. An important step into the market for Galileo is the timely availability of these hybrid multi-mode terminals for consumer applications. However, receiver architectures that are amenable to high-levels of integration will inevitably suffer from RF impairments hindering their easy widespread use in commercial products. This paper studies and presents analytical evaluations of the performance degradation due to the RF impairments and develops algorithms that can compensate for them in the DSP domain at the base band with complexity-reduced hardware overheads, hence, paving the way for low-power, highly integrated multi-mode GNSS receivers.

Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses

Desmoid-type fibromatoses are locally aggressive and frequently recurrent tumours, and an accurate diagnosis is essential for patient management. The majority of sporadic lesions harbour beta-catenin (CTNNB1) mutations. We used next-generation sequencing to detect CTNNB1 mutations and to compare the sensitivity and specificity of next-generation sequencing with currently employed mutation detection techniques: mutation-specific restriction enzyme digestion and polymerase chain reaction amplification. DNA was extracted from formalin-fixed paraffin-embedded needle biopsy or resection tissue sections from 144 patients with sporadic desmoid-type fibromatoses, four patients with syndrome-related desmoid-type fibromatoses and 11 morphological mimics. Two primer pairs were designed for CTNNB1 mutation hotspots. Using ≥10 ng of DNA, libraries were generated by Fluidigm and sequenced on the Ion Torrent Personal Genome Machine. Next-generation sequencing had a sensitivity of 92.36 % (133/144, 95 % CIs: 86.74 to 96.12 %) and a specificity of 100 % for the detection of CTNNB1 mutations in desmoid-type fibromatoses-like spindle cell lesions. All mutations detected by mutation-specific restriction enzyme digestion were identified by next-generation sequencing. Next-generation sequencing identified additional mutations in 11 tumours that were not detected by mutation-specific restriction enzyme digestion, two of which have not been previously described. Next-generation sequencing is highly sensitive for the detection of CTNNB1 mutations. This multiplex assay has the advantage of detecting additional mutations compared to those detected by mutation-specific restriction enzyme digestion (sensitivity 82.41 %). The technology requires minimal DNA and is time- and cost-efficient.